Close Menu

NIGMS

The NIGMS repository holds and distributes over 11,700 unique cell lines, as well as more than 6,300 DNA samples, representing over 1,000 heritable diseases.

The research team is developing a computational system for studying the relationship between RNA structure and function.

The firm will use the award to develop silica nanomaterial for use with many sample types, including blood, cultured cells, and pathogens.

The effort, dubbed the National Resource for Translational and Developmental Proteomics, aims to improve on the technology and train others in its use.

The funds will be used to expand the PharmGKB database and support the activities of the Clinical Pharmacogenetics Implementation Consortium.

Vanderbilt received the grant from NIGMS to establish a new personalized medicine and pharmacogenomics research center.

The grant will help create the new core as part of the existing South Carolina Center of Biomedical Research Excellence (COBRE) for cardiovascular disease.

Just One for You

The US National Institute of General Medical Sciences announces a plan to limit grants to already well-supported investigators.

NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences will provide up to $2 million per year to renew funding for each of the National Centers for Systems Biology, pending approval of renewal applications, the institute said in an announcement Monday.

NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences plans to spend up to $2.4 million in 2015 to fund the Pharmacogenomics Knowledge Base (PharmGKB), a program that supports pharmacogenomics researchers, and has opened

Pages

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

Direct-to-consumer genetic testing companies searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.